- Tumors1000+
- Pathologic Processes1000+
- Nervous System Diseases1000+
- Pathology1000+
- Mental Disorders1000+
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors1000+
- Pathologic Processes1000+
- Nervous System Diseases1000+
- Pathology1000+
- Mental Disorders1000+
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- ER positive
- HER2 positive
- EGFR positive
- KRAS positive
- PR positive
- BRAF positive
- EGFR negative
- PD-L1 negative
- ALK negative
- ER negative
- PR negative
- CD20 positive
- BRCA1 positive
- ALK positive
- IDH positive
- BRCA2 positive
- BRAF negative
- ROS1 negative
- p16 positive
- HLA-A positive
- HR positive
- MET positive
- TP53 positive
- HLA positive
- ROS1 positive
- CD19 positive
- IDH negative
- MYC positive
- NRAS positive
- dMMR positive
- ANA positive
- MSI-H positive
- PIK3CA positive
- p16 negative
- BCR-ABL1 positive
- NF1 positive
- PALB2 positive
- anti-dsDNA positive
- MET negative
- RAS positive
- RET positive
- HPV negative
- HPV positive
- MSS positive
- KRAS negative
- RET negative
- ctDNA positive
- BCL2 positive
- CFTR positive
- FGFR2 positive
- HRAS positive
- NTRK negative
- NTRK positive
- RAS negative
- anti-Sm positive
- HBsAg positive
- MGMT negative
- TP53 negative
- ATM positive
- BCL6 positive
- BRCA positive
- BRCA1 negative
- BRCA2 negative
- CCND1 positive
- COL7A1 positive
- DMD positive
- FGFR3 positive
- GPC3 positive
- HLA negative
- HLA-A negative
- KIT positive
- MMR negative
- MTAP positive
- PTEN positive
- RB1 negative
- RB1 positive
- ABCA4 positive
- CD30 positive
- FMR1 positive
- HbSS positive
- KMT2A positive
- MDM2 positive
- MGMT positive
- MLH1 positive
- MMR positive
- MSH2 positive
- MSH6 positive
- MSI-H negative
- NPM1 positive
- Ph positive
- Philadelphia chromosome negative
- Philadelphia chromosome positive
- RF positive
- TROP2 negative
- TROP2 positive
- dMMR negative
- p53 positive
- pMMR positive
- APC positive
- APOL1 positive
- APP positive
- ARID1A positive
- C5 positive
- CD123 positive
- DLL3 positive
- Ex19del positive
- FGFR positive
- FLT3 positive
- HBB positive
- HBV DNA positive
- HR negative
- L858R positive
- NF2 positive
- NRAS negative
- NUP98 positive
- NY-ESO-1 positive
- PD-1 negative
- PD-1 positive
- PMS2 positive
- PSEN1 positive
- PSEN2 positive
- PiZZ positive
- RAF positive
- RHO positive
- SMARCA4 positive
- SPINK5 positive
- STK11 positive
- T790M positive
- TET2 positive
- anti-AChR positive
- t(11;14) positive
- 11q negative
- 11q positive
- AChR positive
- AKT negative
- ALPL positive
- ARAF positive
- Anti-PLA2R positive
- Aβ1-42 positive
- BCR::ABL1 positive
- CD22 positive
- CD30 negative
- CD5 positive
- CDK4 positive
- CHEK2 positive
- CLDN18.2 positive
- COL1A1 positive
- COL1A2 positive
- CRAF positive
- CRLF2 positive
- DMPK positive
- EBV DNA positive
- EBV positive
- EPCAM positive
- ER/PR positive
- FGFR2 negative
- FLT3 negative
- FOXO1 fusion negative
- GRN positive
- H3 K27M positive
- HBV DNA negative
- HBsAg negative
- HEXA positive
- HEXB positive
- HPV16 positive
- HTT positive
- HbSβ0-thalassemia positive
- IGHV positive
- JAK2 positive
- Ki67 positive
- LRRK2 positive
- MECP2 positive
- MSI negative
- MSS negative
- MYD88 L265P positive
- MuSK positive
- NF1 negative
- NTRK1 positive
- PAH positive
- PDE6A positive
- PDE6B positive
- PIK3CA negative
- PIK3CD positive
- PIK3R1 positive
- PKLR positive
- PKP2 positive
- PMM2 positive
- PRSS1 positive
- PSMA positive
- PTCH1 positive
- PTEN negative
- PTPN11 positive
- RUNX1 positive
- SMN1 positive
- SOD1 positive
- SOS1 positive
- T315I positive
- TSC1 positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Chemotherapy without Concurrent Biologic/Targeted Therapy
- Adjuvant Therapy (except reconstruction)
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Beovu
- Biologic Anti-Neoplastic Agent
- Branch Retinal Vein Occlusion (BRVO)
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
8409 trials
1
2
3
…50